Genome & Company314130 
$1.85-1.64%24h
-1.64%24h
Global rank26486
Market cap$26.11M
Change 7d-5.43%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Genome & Company (314130)
As of January 2025, Genome & Company has a market cap of $26.11M. This makes Genome & Company the world's 26486th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Genome & Company from 2021 to 2024
-
Value:-
Market cap history of Genome & Company from 2021 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $90.32M | -25.22% |
| 2023 | $120.78M | -28.42% |
| 2022 | $168.74M | -50.00% |
| 2021 | $337.48M | - |
314130 Market Cap Today is $26.11M -1.64% - 22 Jan 2025
View largest stocks by market cap 
